Back

Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study

18 March 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes Arrhythmias, General – Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Zoraida L Moreno Weidmann

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

33 More presentations in this session

Presentation thumbnail
Professor T. Neumann (Nauheim, DE)
Abstract
Presentation thumbnail
Doctor A. Billiet (Leuven, BE)
Abstract Slides
Presentation thumbnail
Doctor K. Nentwich (Bad Neustadt an der Saale, DE)
Abstract Slides
Presentation thumbnail
Doctor M. Forkmann (Coburg, DE)
Abstract
Presentation thumbnail
Doctor A. Vevecka (Würzburg, DE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes

The Event

Event poster

EHRA 2018

18 March 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources